SynAct Pharma AB
STO:SYNACT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gujarat Alkalies And Chemicals Ltd
NSE:GUJALKALI
|
IN |
|
Guangdong Goworld Co Ltd
SZSE:000823
|
CN |
|
Shenzhen Inovance Technology Co Ltd
SZSE:300124
|
CN |
|
P
|
Pilani Investment And Industries Corporation Ltd
NSE:PILANIINVS
|
IN |
SynAct Pharma AB
Accounts Payable
SynAct Pharma AB
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SynAct Pharma AB
STO:SYNACT
|
Accounts Payable
kr9.5m
|
CAGR 3-Years
26%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Biogaia AB
STO:BIOG B
|
Accounts Payable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Accounts Payable
kr16.4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Accounts Payable
kr208m
|
CAGR 3-Years
5%
|
CAGR 5-Years
52%
|
CAGR 10-Years
25%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Accounts Payable
kr1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
21%
|
|
|
BioArctic AB
STO:BIOA B
|
Accounts Payable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SynAct Pharma AB
Glance View
SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. The company is headquartered in Lund, Skane. The company went IPO on 2016-07-11. The firm is located in Lund, Sweden. The company develops medicines for acute impairment in inflammatory diseases. The firm's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.
See Also
What is SynAct Pharma AB's Accounts Payable?
Accounts Payable
9.5m
SEK
Based on the financial report for Dec 31, 2025, SynAct Pharma AB's Accounts Payable amounts to 9.5m SEK.
What is SynAct Pharma AB's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
28%
Over the last year, the Accounts Payable growth was -45%. The average annual Accounts Payable growth rates for SynAct Pharma AB have been 26% over the past three years , 28% over the past five years .
